MedPath

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Private, Subsidiary
Established
1891-01-01
Employees
10K
Market Cap
-
Website
http://www.medschool.wustl.edu

Prophylactic Incisional Care in Obese Women at Cesarean

Not Applicable
Completed
Conditions
Wound Infections
Interventions
Other: Standard Dressing
Device: Prophylactic NPWT (PICO system)
First Posted Date
2015-10-19
Last Posted Date
2019-11-27
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
120
Registration Number
NCT02578745
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Barnes-Jewish Hospital, Saint Louis, Missouri, United States

The Predictive Value of Ureteral Jet Assessment With Ultrasound in Patients Presenting With Acute Renal Colic

Not Applicable
Completed
Conditions
Ureteral Calculi
Interventions
Device: renal and bladder ultrasound with ureteral jet assessment
First Posted Date
2015-10-16
Last Posted Date
2019-12-10
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
74
Registration Number
NCT02577146
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Washington University School of Medicine, Saint Louis, Missouri, United States

Staph Household Intervention for Eradication (SHINE)

Phase 4
Active, not recruiting
Conditions
Skin and Subcutaneous Tissue Bacterial Infections
Staphylococcus Aureus
MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Interventions
Drug: Chlorhexidine
Drug: Mupirocin
Behavioral: Household cleaning
First Posted Date
2015-10-09
Last Posted Date
2024-05-23
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
835
Registration Number
NCT02572791
Locations
๐Ÿ‡บ๐Ÿ‡ธ

St. Louis Children's Hospital, Saint Louis, Missouri, United States

๐Ÿ‡บ๐Ÿ‡ธ

Washington University School of Medicine, Saint Louis, Missouri, United States

Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)

Phase 2
Completed
Conditions
Squamous Cell Carcinoma of the Head and Neck
Carcinoma, Squamous Cell of the Head and Neck
Cancer of Head and Neck
Cancer of the Head and Neck
Head and Neck Cancer
Neoplasms, Head and Neck
Interventions
Drug: nab-Paclitaxel
Biological: Cetuximab
Drug: Cisplatin
Radiation: Intensity-Modulated Radiation Therapy
First Posted Date
2015-10-09
Last Posted Date
2024-12-27
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
96
Registration Number
NCT02573493
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Sanford Cancer Center, Sioux Falls, South Dakota, United States

๐Ÿ‡บ๐Ÿ‡ธ

The University of Kansas Cancer Center and Medical Pavilion, Westwood, Kansas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Washington University School of Medicine, Saint Louis, Missouri, United States

Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)

Phase 1
Withdrawn
Conditions
Myeloproliferative Neoplasm
Chronic Myelomonocytic Leukemia
Myelodysplastic Syndromes
Juvenile Myelomonocytic Leukemia
Atypical Chronic Myeloid Leukemia
Myelofibrosis
Interventions
First Posted Date
2015-09-30
Last Posted Date
2017-05-08
Lead Sponsor
Washington University School of Medicine
Registration Number
NCT02564536

SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer

Not Applicable
Completed
Conditions
Nonsmall Cell Lung Cancer
Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell-Lung
Interventions
Behavioral: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30
Behavioral: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire LC-13
Behavioral: Modified Medical Research Council
Behavioral: EQ-5D
Behavioral: Center for Epidemiological Studies Depression Scale
Behavioral: Medical Outcomes Study Social Support Survey
First Posted Date
2015-09-29
Last Posted Date
2021-04-08
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
217
Registration Number
NCT02562027
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Washington University School of Medicine, Saint Louis, Missouri, United States

Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy

Recruiting
Conditions
Central Nervous System
Interventions
Other: NIH Toolbox Cognitive Battery
First Posted Date
2015-09-24
Last Posted Date
2024-04-24
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
80
Registration Number
NCT02559752
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Washington University School of Medicine, Saint Louis, Missouri, United States

Genomic Landscape of Ceritinib

Terminated
Conditions
Carcinoma, Non-Small-Cell Lung
Non-Small Cell Lung Cancer
Non-small Lung Cancer
First Posted Date
2015-09-18
Last Posted Date
2018-03-05
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
6
Registration Number
NCT02554591
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Washington University School of Medicine, Saint Louis, Missouri, United States

Treatment of Chronic Stroke With IpsiHand

Not Applicable
Completed
Conditions
Stroke
Interventions
Device: IpsiHand Device
First Posted Date
2015-09-17
Last Posted Date
2018-09-17
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
23
Registration Number
NCT02552368
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Washington University School of Medicine, Saint Louis, Missouri, United States

Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer

Phase 1
Completed
Conditions
Advanced Solid Tumors
Solid Tumors
Pancreatic Cancer
Interventions
Biological: Defactinib
Biological: Pembrolizumab
Drug: Gemcitabine
First Posted Date
2015-09-11
Last Posted Date
2021-07-20
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
43
Registration Number
NCT02546531
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Washington University School of Medicine, Saint Louis, Missouri, United States

๐Ÿ‡บ๐Ÿ‡ธ

Mayo Clinic, Rochester, Minnesota, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath